Morgan Stanley Maintains Overweight on Humana, Lowers Price Target to $624
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Michael Ha has maintained an Overweight rating on Humana (NYSE:HUM) but lowered the price target from $637 to $624.

August 30, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has maintained an Overweight rating on Humana but lowered the price target from $637 to $624.
The news is directly related to Humana. While the Overweight rating suggests that Morgan Stanley expects the stock to outperform, the lowering of the price target might create some negative sentiment among investors. However, since the rating remains Overweight, the overall impact is expected to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100